Avient (AVNT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Nov, 2025Executive summary
Achieved fourth consecutive quarter of organic growth, with Q1 2025 organic sales up 2% year-over-year, driven by packaging and healthcare, while transportation and defense lagged.
Adjusted EPS was $0.76, up 4% year-over-year excluding FX, and in line with guidance; GAAP EPS was ($0.22) due to special items, including an $86.3 million ERP impairment.
Adjusted EBITDA margin expanded by 20 basis points to 17.5% due to favorable mix and cost discipline.
Net loss attributable to common shareholders was $20.2 million, compared to net income of $49.4 million in Q1 2024, mainly due to the ERP impairment.
Organic sales growth achieved despite macroeconomic volatility and weak U.S. consumer and transportation demand.
Financial highlights
Q1 2025 sales were $826.6 million, down 0.3% as reported but up 2% organically year-over-year, with adjusted EBITDA of $144.7 million, up 4% organically.
Adjusted EPS was $0.76, flat year-over-year, with prior-year Q1 having grown 21% over Q1 2023.
Gross margin (GAAP) was 31.8%, down from 33.6% year-over-year; adjusted gross margin was 32.8% of sales.
Net cash used by operating activities was $51.1 million, up from $42.8 million in Q1 2024, reflecting higher incentive compensation and working capital needs.
Cash and cash equivalents at quarter-end were $456.0 million; total liquidity including revolver availability was $711.1 million.
Outlook and guidance
Full-year 2025 adjusted EPS guidance remains $2.70–$2.94; adjusted EBITDA guidance unchanged at $540–$570 million.
Q2 2025 adjusted EPS expected at $0.79, representing 4% growth year-over-year.
Company plans to pay down $100–$200 million of debt by year-end, supported by strong cash position and free cash flow expectations.
Guidance range unchanged despite increased macro uncertainty; scenarios modeled for flat to mid-single digit growth or declines in the second half.
Ongoing restructuring and integration of Clariant Color expected to complete by end of 2025, with $70 million in total charges anticipated.
Latest events from Avient
- Record margin and EPS growth in 2025; 2026 guidance targets further gains amid uncertainty.AVNT
Q4 202512 Feb 2026 - Q2 2024 delivered 21% EPS growth, margin gains, and higher full-year guidance.AVNT
Q2 20242 Feb 2026 - Q3 sales up 8%, adjusted EPS up 14%, and full-year guidance raised amid broad-based growth.AVNT
Q3 202417 Jan 2026 - Targets 20%+ EBITDA margin and double-digit EPS growth through organic expansion in high-growth markets.AVNT
Investor Day 202411 Jan 2026 - 2024 delivered strong growth and margin gains, with double-digit adjusted EPS growth.AVNT
Q4 202414 Dec 2025 - 2025 proxy covers director elections, executive pay, auditor ratification, and ESG progress.AVNT
Proxy Filing1 Dec 2025 - Key votes include board elections, executive pay, and auditor ratification at the 2025 meeting.AVNT
Proxy Filing1 Dec 2025 - Q2 2025 saw 2% sales growth, 5% EPS gain, margin expansion, and strong cash flow.AVNT
Q2 202516 Nov 2025 - Q3 2025 adjusted EPS up to $0.70; margin expansion and debt repayment offset weak sales.AVNT
Q3 202513 Nov 2025